Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesUrothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features
Human Pathology, 09/22/09
Hodges KB et al. – Recent molecular studies have provided further insight into the premalignant potential of these urothelial lesions. Herein, the authors present a review of flat urothelial lesions of the urinary bladder as defined by the 2004 World Health Organization classification with focus on the clinicopathologic, immunohistochemical, and molecular features.
Related Articles
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer
European Journal of Cancer, 10/20/09
Relevance Score: 46%
Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion
European Journal of Cancer, 11/19/09
Relevance Score: 45%
CD10 expression in urothelial carcinoma of the bladder
Diagnostic Pathology, 11/23/09
Relevance Score: 44%
Functional Transient Receptor Potential Vanilloid 1 is Expressed in Human Urothelial Cells
The Journal of Urology, 11/23/09
Relevance Score: 43%
Grading of gastric foveolar-type dysplasia in Barrett's esophagus
Modern Pathology, 10/23/09
Relevance Score: 43%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome
International Journal of Urology, 12/04/09
XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
Journal of Cancer Research & Clinical Oncology, 12/04/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Article Search
Sponsor